UA88018C2 - Potassium channel inhibitors - Google Patents
Potassium channel inhibitorsInfo
- Publication number
- UA88018C2 UA88018C2 UAA200702125A UAA200702125A UA88018C2 UA 88018 C2 UA88018 C2 UA 88018C2 UA A200702125 A UAA200702125 A UA A200702125A UA A200702125 A UAA200702125 A UA A200702125A UA 88018 C2 UA88018 C2 UA 88018C2
- Authority
- UA
- Ukraine
- Prior art keywords
- potassium channel
- channel inhibitors
- inhibitors
- compounds
- useful
- Prior art date
Links
- 102000004257 Potassium Channel Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 108020001213 potassium channel Proteins 0.000 title abstract 2
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to compounds having the structure Formula (I) useful as potassium channel inhibitors to treat cardiac arrhythmias.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59218104P | 2004-07-29 | 2004-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA88018C2 true UA88018C2 (en) | 2009-09-10 |
Family
ID=35613661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200702125A UA88018C2 (en) | 2004-07-29 | 2005-07-25 | Potassium channel inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| KR (1) | KR20070043985A (en) |
| AR (1) | AR049847A1 (en) |
| BR (1) | BRPI0513793A (en) |
| CR (1) | CR8876A (en) |
| EC (1) | ECSP077208A (en) |
| IL (1) | IL180846A0 (en) |
| MA (1) | MA28980B1 (en) |
| MX (1) | MX2007001188A (en) |
| NO (1) | NO20071107L (en) |
| PE (1) | PE20060382A1 (en) |
| RU (1) | RU2344134C2 (en) |
| TW (1) | TW200607493A (en) |
| UA (1) | UA88018C2 (en) |
| WO (1) | WO2006028590A1 (en) |
| ZA (1) | ZA200700477B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010225405B2 (en) * | 2009-03-18 | 2014-10-23 | Medicure International Inc. | Transdermal pharmaceutical preparation and administration of tirofiban |
| CA2876359C (en) | 2012-06-11 | 2020-01-21 | Bristol-Myers Squibb Company | Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino) quinazolin-2-yl] pyridine-3-sulfonamide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2140865B2 (en) * | 1971-08-14 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | 1-imidazolyl-methanephosphonic acid ester, process for their preparation and medicaments containing them |
| DE19951701A1 (en) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Use of 2-imidazolyl-substituted carbinols for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions |
| EP2292595A1 (en) * | 2002-01-04 | 2011-03-09 | NeuroSearch AS | Potassium channel modulators |
-
2005
- 2005-07-19 AR ARP050102975A patent/AR049847A1/en unknown
- 2005-07-22 PE PE2005000858A patent/PE20060382A1/en not_active Application Discontinuation
- 2005-07-22 TW TW094125011A patent/TW200607493A/en unknown
- 2005-07-25 KR KR1020077002228A patent/KR20070043985A/en not_active Withdrawn
- 2005-07-25 BR BRPI0513793-4A patent/BRPI0513793A/en not_active IP Right Cessation
- 2005-07-25 WO PCT/US2005/026334 patent/WO2006028590A1/en not_active Ceased
- 2005-07-25 MX MX2007001188A patent/MX2007001188A/en unknown
- 2005-07-25 RU RU2007107408/04A patent/RU2344134C2/en not_active IP Right Cessation
- 2005-07-25 UA UAA200702125A patent/UA88018C2/en unknown
-
2007
- 2007-01-16 ZA ZA200700477A patent/ZA200700477B/en unknown
- 2007-01-21 IL IL180846A patent/IL180846A0/en unknown
- 2007-01-25 CR CR8876A patent/CR8876A/en not_active Application Discontinuation
- 2007-01-26 EC EC2007007208A patent/ECSP077208A/en unknown
- 2007-02-21 MA MA29689A patent/MA28980B1/en unknown
- 2007-02-27 NO NO20071107A patent/NO20071107L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200607493A (en) | 2006-03-01 |
| PE20060382A1 (en) | 2006-05-15 |
| KR20070043985A (en) | 2007-04-26 |
| CR8876A (en) | 2007-08-28 |
| WO2006028590A1 (en) | 2006-03-16 |
| RU2344134C2 (en) | 2009-01-20 |
| AR049847A1 (en) | 2006-09-06 |
| MA28980B1 (en) | 2007-11-01 |
| MX2007001188A (en) | 2007-03-21 |
| NO20071107L (en) | 2007-04-19 |
| BRPI0513793A (en) | 2008-05-13 |
| ECSP077208A (en) | 2007-02-28 |
| IL180846A0 (en) | 2007-06-03 |
| RU2007107408A (en) | 2008-09-10 |
| ZA200700477B (en) | 2009-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007085895A3 (en) | Fap inhibitors | |
| ZA200802848B (en) | Potassium channel inhibitors | |
| TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
| WO2006015159A3 (en) | Potassium channel inhibitors | |
| WO2005030129A3 (en) | Quinoline potassium channel inhibitors | |
| MXPA04008613A (en) | New compounds. | |
| TN2012000063A1 (en) | Quinazolines as potassium ion channel inhibitors | |
| TW200626068A (en) | Active compounds for seed treatment | |
| BR0313330A (en) | Pyrrolidinedione-substituted piperidine-phthalazones as pde4 inhibitors | |
| WO2005030130A3 (en) | Isoquinoline potassium channel inhibitors | |
| UA83875C2 (en) | Quinoline derivatives for use as mycobacterial inhibitors | |
| TW200728290A (en) | Chemical compounds | |
| EA200801608A1 (en) | DERIVATIVES OF BENZIMIDAZOLONIC CARBONIC ACID | |
| IL189883A0 (en) | Isoquinolines as igf-1r inhibitors | |
| ATE549024T1 (en) | QUINAZOLINE POTASSIUM CHANNEL INHIBITORS | |
| DE602004028493D1 (en) | Isoquinolinone POTASSIUM CHANNEL INHIBITORS | |
| TW200738686A (en) | Chemical compounds | |
| WO2007050348A3 (en) | Potassium channel inhibitors | |
| WO2005030792A3 (en) | Quinoline potassium channel inhibitors | |
| ATE417849T1 (en) | PYRAZOLOA4,3-DÜPYRIMIDINE | |
| ATE542796T1 (en) | N-SULFONYLCARBOXIMIDAMIDE COMPOUNDS AS APOPTOSIS PROMOTERS | |
| TNSN06260A1 (en) | Process for the preparation of tryptase inhibitors | |
| WO2007089735A3 (en) | Potassium channel inhibitors | |
| WO2006014877A3 (en) | Potassium channel inhibitors | |
| UA88018C2 (en) | Potassium channel inhibitors |